Ordenar

Buscar

01/10/2025 Non-Pharmacological Dermatologic Care for the Prevention and Management of Immune-Related Skin Toxicities in Patients With Lung Cancer
Lopez, JS, Besora, CP, Verge, MM, Joaquin, AB, Recio, SM, Pastor, M, Fierro, JP, Martinez-Esparza, EH, Martinez-Momblan, MA, Majem, M. Non-Pharmacological Dermatologic Care for the Prevention and Management of Immune-Related Skin Toxicities in Patients With Lung Cancer. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).
01/10/2025 Histological Transformation as Resistance Mechanism in NSCLC: A Multicenter Study Exploring Clinico-Pathological and Molecular Features
Torresan, S, Torres, CSD, Caramella, C, Ambrosini, P, Gomez-Randulfe, I, Monaca, F, Ribera, A, Goudsmit, A, Michelini, A, Segui, V, Insa, A, Martorell, PM, Romero-Sola, G, Caro-Consuegra, R, Mirallas, O, Priano, I, Valdivia, A, Masfarré, L, Iranzo, P, Martinez-Marti, A, Cedres, S, Catot, S, Sequeira, T, Callejo, A, Bearz, A, Barba, A, Antoñanzas, M, Sais, E, Baena, J, Brandao, M, Mosteiro, M, Vilariño, N, Gambardella, V, Moran, T, Occhipinti, M, Califano, R, Pardo, N, Felip, E, Rocha, P. Histological Transformation as Resistance Mechanism in NSCLC: A Multicenter Study Exploring Clinico-Pathological and Molecular Features. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).
01/10/2025 Benefits of Adjuvant Alectinib in ALK plus Early-Stage Non-Small Cell Lung Cancer, Recurrences Avoided and Savings for the Spanish Health System
De Castro, J, Bernabé, R, Escudero, V, Gutiérrez, F, Majem, M, Gordo, R, Arroyo, I, Arranz, S, Collado, R. Benefits of Adjuvant Alectinib in ALK plus Early-Stage Non-Small Cell Lung Cancer, Recurrences Avoided and Savings for the Spanish Health System. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).
01/10/2025 IMscin002 Final Analysis: Patient Preference and Safety of Atezolizumab by Subcutaneous and Intravenous Administration
Cappuzzo, F, Zvirbule, Z, Korbenfeld, E, Kolb-Sielecki, J, Isla, D, Sanchez, AYC, Bustillos, A, Herraez-Baranda, L, Barata, T, Young, F, Majem, M. IMscin002 Final Analysis: Patient Preference and Safety of Atezolizumab by Subcutaneous and Intravenous Administration. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).
01/10/2025 A Multinational Phase 2 Randomized Pivotal Study of Sunvozertinib in Pretreated NSCLC With EGFR Exon 20 Insertion Mutations
Wang, M, Jänne, PA, Doucet, L, Fan, Y, Lv, D, Sun, M, Huang, D, Greillier, L, Planchard, D, Hong, Q, Mazieres, J, Felip, E, Li, X, Hu, Y, Fang, J, Bazhenova, L, Ghiringhelli, F, Dols, MAC, Rodriguez, LPA, Bearz, A, Ferreira, BP, Kim, YJ, Bosch-Barrera, J, Shim, BY, Luo, YH, Tiseo, M, Yang, TY, Carcereny, E, Memmott, R, Zalcman, G, Carpeño, JD, Di Noia, V, Parra, HS, Streich, G, Lee, D, Shum, E, Han, JY, Jaime, JC, Brungs, D, John, T, D'Arcangelo, M, Joaquín, AB, Liu, G, Antonuzzo, L, Fernandez-Hinojal, G, Le, X, Zheng, L, Yang, JCH. A Multinational Phase 2 Randomized Pivotal Study of Sunvozertinib in Pretreated NSCLC With EGFR Exon 20 Insertion Mutations. Journal of Thoracic Oncology. 2025; 20(10)DOI:. PMID:. IF:20.800(Q1/1D).
01/10/2025 FROM GUT TO BRAIN: THE MICROBIOME'S INFLUENCE ON INFECTIONS AFTER INTRACEREBRAL HEMORRHAGE INTRACRANIAL HEMORRHAGE
Prats-Sanchez, L, Lledos, M, Ezcurra, G, Martí-Fàbregas, J, Lambea-Gil, A, Guasch, M, Martínez-Domeño, A, Fernandez-Vidal, JM, Ramos-Pachon, A, Villatoro-González, P, Puig, N, Simon, AA, Fernández-Cadenas, I, Camps-Renom, P. FROM GUT TO BRAIN: THE MICROBIOME'S INFLUENCE ON INFECTIONS AFTER INTRACEREBRAL HEMORRHAGE INTRACRANIAL HEMORRHAGE. International Journal of Stroke. 2025; 20(2_SUPPL)DOI:. PMID:. IF:8.700(Q1/1D).
01/10/2025 PREDICTORS OF EARLY WITHDRAWAL OF CARE IN PATIENTS WITH ACUTE INTRACEREBRAL HEMORRHAGE: A POPULATION-BASED STUDY
Lambea-Gil, A, Martí-Fàbregas, J, Guasch, M, Ezcurra-Diaz, G, Fernandez-Vidal, JM, Prats-Sanchez, L, Martínez-Domeño, A, Camps-Renom, P, Ramos-Pachon, A. PREDICTORS OF EARLY WITHDRAWAL OF CARE IN PATIENTS WITH ACUTE INTRACEREBRAL HEMORRHAGE: A POPULATION-BASED STUDY. International Journal of Stroke. 2025; 20(2_SUPPL)DOI:. PMID:. IF:8.700(Q1/1D).
01/10/2025 EXTERNAL VALIDATION OF TWO PREDICTIVE SCORES FOR HEMORRHAGIC TRANSFORMATION FOLLOWING ENDOVASCULAR THROMBECTOMY IN A POPULATION-BASED STUDY
Romeu, MD, Guasch, M, Ezcurra, G, Lambea-Gil, A, Ramos-Pachon, A, Martínez-Domeño, A, Prats-Sanchez, L, Fernandez-Vidal, JM, Toscano-Prat, C, Martí-Fàbregas, J, Martínez-González, JP, Fernández-Cadenas, I, Cardona, P, Rodriguez-Villatoro, N, Rodríguez-Vázquez, A, Gomis, M, Xuclà-Ferrarons, T, Rodríguez-Campello, A, Cánovas, D, Sero, L, Purroy, F, Salvat-Plana, M, Abilleira, S, Camps-Renom, P. EXTERNAL VALIDATION OF TWO PREDICTIVE SCORES FOR HEMORRHAGIC TRANSFORMATION FOLLOWING ENDOVASCULAR THROMBECTOMY IN A POPULATION-BASED STUDY. International Journal of Stroke. 2025; 20(2_SUPPL)DOI:. PMID:. IF:8.700(Q1/1D).